As healthcare professionals, we encounter pyrexia, or fever, regularly in clinical practice. Despite its common occurrence, its management can be complex, necessitating a comprehensive understanding of its etiology, pathophysiology, and treatment options.
Pyrexia is a physiological response to various conditions, most commonly infections. It results from the release of pyrogens, which reset the hypothalamic temperature set-point, leading to increased body temperature. Understanding the underlying cause is crucial in managing pyrexia effectively.
Assessment of the febrile patient should include a thorough history and physical examination. Key factors to consider are the duration and pattern of the fever, associated symptoms, and potential exposure to infectious agents. Laboratory investigations, such as complete blood count, inflammatory markers, and cultures, can provide valuable information.
Treatment of pyrexia primarily focuses on addressing the underlying cause. In cases of infection, appropriate antibiotics should be administered. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs, can be used to alleviate discomfort but should not replace the treatment of the underlying cause. In some cases, pyrexia can be a helpful physiological response, enhancing immune function and inhibiting pathogen growth.
Special considerations should be given to immunocompromised patients, as their fevers may indicate serious infections. Elderly patients may present atypically, with confusion or falls instead of fever. In neonates, pyrexia may be the only sign of serious bacterial infection and warrants immediate investigation.
In conclusion, managing pyrexia in clinical practice requires a comprehensive approach, understanding its etiology, conducting a thorough assessment, and implementing appropriate treatment. Special attention should be given to vulnerable populations. As healthcare professionals, our role is not just to treat the fever, but to understand and address its underlying cause.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation